Moderna, the biotech that rose to fame for making one of the world’s first Covid-19 vaccines, has hit a new milestone: its first non-Covid product, which could give the company a much-needed boost as ...

Sept 23 (Reuters) - Moderna (MRNA.O), opens new tab said on Tuesday its updated COVID-19 vaccine formulation elicited a strong immune response in all adults aged 65 and older, as well as in ...

Moderna (MRNA) stock traded more than 12% higher on Tuesday following several headline events. Late Monday afternoon, the Louisiana Department of Health reported the first Bird Flu-related human death ...

Pfizer Inc.'s (NYSE:PFE) COVID-19 vaccine for children under five may lose U.S. Food and Drug Administration authorization this fall, raising the possibility of supply shortages and prompting Moderna ...

Moderna, Inc. (MRNA) shares were up over 3% in choppy trading on Friday afternoon, even as the biotech firm reported a wider-than-expected quarterly loss and issued a 2025 revenue forecast with a ...